Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
出版年份 2016 全文链接
标题
Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
作者
关键词
Targeted alpha therapy, <sup>213</sup>Bi-DOTATATE, Nephrotoxicity, Maximum tolerated dose, <span class=EmphasisTypeSmallCaps >l
出版物
EJNMMI Research
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-21
DOI
10.1186/s13550-016-0240-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate
- (2016) Ho Sze Chan et al. EJNMMI Research
- Biomarkers of renal function, which and when?
- (2015) Michael E. Wasung et al. CLINICA CHIMICA ACTA
- Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course
- (2015) Hendrik Bergsma et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Utilizing High-Energy -Photons for High-Resolution 213Bi SPECT in Mice
- (2015) J. de Swart et al. JOURNAL OF NUCLEAR MEDICINE
- 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
- (2014) C. Kratochwil et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
- (2014) Lisa Bodei et al. Thoracic Surgery Clinics
- Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody
- (2013) H. Song et al. MOLECULAR CANCER THERAPEUTICS
- Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy
- (2012) Peter Kletting et al. MEDICAL PHYSICS
- A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry
- (2012) Robert F Hobbs et al. PHYSICS IN MEDICINE AND BIOLOGY
- Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
- (2011) D. Wild et al. CANCER RESEARCH
- Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides
- (2010) Erik de Blois et al. APPLIED RADIATION AND ISOTOPES
- Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage
- (2008) Davide Bolignano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury
- (2008) P. Devarajan NEPHROLOGY DIALYSIS TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started